Neurological morbidity among human T-lymphotropic-virus-type-1-infected individuals in a rural West African population

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 1, 2009, Pages 66-68

  Cooper, S ^a   Van Der Loeff, M Schim ^b   McConkey, S ^c   Cooper, M ^d   Sarge Njie, R ^e   Kaye, S ^f   Whittle, H ^e  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b MUNICIPAL HEALTH SERVICE   (Netherlands)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACKACHE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SEROLOGY; SPASTIC PARAPLEGIA; T LYMPHOCYTE; WEAKNESS; CROSS-SECTIONAL STUDY; GUINEA-BISSAU; HUMAN T CELL LEUKEMIA VIRUS 1; MIDDLE AGED; RURAL POPULATION; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GUINEA-BISSAU; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PARAPARESIS, TROPICAL SPASTIC; PREVALENCE; RURAL POPULATION; YOUNG ADULT;

EID: 58249089517     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.152819     Document Type: Article

References (23)

1. de The G, Bomford R. An HTLV-1 vaccine: why, how, for whom? AIDS Res Hum retroviruses 1993; 9:381-6
2. Gessain A, Mahieux R. Epidemiology, origin and genetic diversity of HTLV-1 retrovirus and STLV-1 simian affiliated retrovirus. Bull Soc Pathol Exot 2000: 93:163-71.
3. Cabre P, Smadja A, Cabie A, et al. HTLV-1 and HIV infections of the central nervous system in tropical areas. J Neurol Neurosurg Psych 2000; 68:550-7.
4. Montgomery RD. The epidemiology of myelopathy associated with human T-cell lymphotropic virus type 1. Trans Roy Soc Med Hyg 1993; 87:154-9.
5. Takenouchi N, Yamano V, Usuku K, et al. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type 1-associated myelopathyAropical spastic papaparesis. J Neurovirol 2003; 9:29-35.
6. Kramer A, Maloney EM, Morgan 0, et al. Risk factors and cofactors for human T-cell lymphotropic virus type 1 (HTLV-1) associated myelopathyAropical spastic paraparesis (HAM/TSP) in Jamaica. Am J Epidemiol 1995; 142:1212-19.
7. Araujo A. and Silva M. The HTLV-1 neurological complex. The Lancet Neurology 2006; 5:1068-76.
8. Verdonck K, Gonzalez E, van Dooren S, et al. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Inf Dis 2007; 7:266-81.
9. Olindo S, Cabre P, Lezin A. Natural history of HTLV-1-associated myelopathy: a 14-year follow-up study. Arch Neurol 2006; 63:1560-6.
10. Larssen O, Andersson S, da Sillva Z, et al. Prevalence of HTLV-1 infection and associated risk determinants in an urban population in Guinea Bissau, West Africa. J Acquir Immune Defic Syndr 2000, 1; 25:157-63.
11. Melbye M, Poulsen AG, Gallo D, et al. HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival. Int J Cancer 1998; 76:293-8.
12. Holmgren B, Andersson S, Harding E, et al. Increased prevalence of HTLV-1 among HIV-1 infected women but not HIV-2 infected men in rural Guinea Bissau. J Acquir Immun Defic Syndr 2002; 30:342-50.
13. World Health Organization. Virus diseases. Human t-cell lymphotropic virus type 1 (HTLV-1). Geneva. Weekly Epidemiological Record. 1989: 49:377-84.
14. Orland JR, Engstrom J, Fridey J, et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV outcome study. Neurology 2003; 61:1588-94.
15. Webb S, Hutchinson M. Cognitive impairment in families with pure autosomal dominant hereditary spastic paraparesis. Brain 1998; 121:923-9.
16. Gessain A, Barin F, Vernanr JC, et al. Antibodies to T cell lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985, 2:407-10.
17. Rodgers-Johnson P, Morgan OStC, Mora C, et al. The role of HTLV-1 in tropical spastic paraparesis in Jamaica. Ann Neurol 1988; 23(Suppl):121-6S.
18. Bhigjee Al, Kelbe C, Haribhai HC, et al. Myelopathy associated with human t cell lymphotropic virus type 1 (HTLV-1) in Natal, South Africa. Brainv 1990; 113:1307-20.
19. Sabouri AH, Satio M, Usuku K, et al. Differences in viral and host genetic risk factors for developmemt of human t cell lymphotropic virus type 1 (HTLV-1) associated myleopathy/spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Genl Virol 2005; 86:773-81.
20. Kumar SP, Ramasubramanian D. The Babinski sign: a reappraisal. Neurol India 2000; 48:314-18.
21. Casseb J, de Oliveira AC, Vergara MP, et al. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1 infected patients. J Med Virol 2008; 80:392-8.
22. Vernant JC, Maurs L, Gessain A, et al. Endemic tropical spastic paraparesis associated with HTLV-1: a clinical and seroepidemiological study of 25 cases. Ann Neuroy 1987; 21:123-30.
23. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, et al. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 2005; 24:6058-68.